• 1. LXVIII.—The absorption spectra of the vapours and solutions of anisole, phenetole, and various derivatives
  John Edward Purvis J. Chem. Soc. Trans. 1915 107 660
• 2. 424. The dissociation constants of the monohalogenated anilines and phenols
  G. M. Bennett,G. L. Brooks,S. Glasstone J. Chem. Soc. 1935 1821
• 3. Formula index
  J. Chem. Soc. Trans. 1915 107 1879
• 4. General and physical chemistry
  J. Chem. Soc. Abstr. 1911 100 ii449
• 5. Organic chemistry
  J. Chem. Soc. Abstr. 1913 104 i813

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers Phenol ethers
• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers
• Pharmaceutical and Biochemical Products Medicinal Building Blocks Fluorine containing Building Blocks
• Solvents and Organic Chemicals Organic Compounds Alcohol/Ether

Recent Advances in the Application of 1-Ethoxy-4-fluorobenzene (CAS: 459-26-7) in Chemical Biology and Pharmaceutical Research

1-Ethoxy-4-fluorobenzene (CAS: 459-26-7) is a fluorinated aromatic compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound, characterized by its ethoxy and fluorine substituents, serves as a valuable building block in the synthesis of complex molecules, including active pharmaceutical ingredients (APIs) and bioactive probes. Recent studies have highlighted its role in facilitating novel synthetic routes, enhancing drug-like properties, and enabling precise molecular modifications. This research brief aims to provide an overview of the latest advancements involving 1-Ethoxy-4-fluorobenzene, focusing on its synthetic utility, biological relevance, and potential therapeutic applications.

One of the most notable developments in the use of 1-Ethoxy-4-fluorobenzene is its incorporation into the design of fluorinated drug candidates. Fluorination is a widely employed strategy in medicinal chemistry to improve metabolic stability, bioavailability, and binding affinity of therapeutic molecules. Researchers have recently reported the successful synthesis of fluorinated analogs of known drugs using 1-Ethoxy-4-fluorobenzene as a key intermediate. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated the utility of this compound in the development of novel kinase inhibitors, where the introduction of the ethoxy-fluorobenzene moiety significantly enhanced target selectivity and reduced off-target effects.

In addition to its role in drug design, 1-Ethoxy-4-fluorobenzene has been utilized in chemical biology as a versatile probe for studying protein-ligand interactions. The fluorine atom in this compound allows for ¹⁹F NMR spectroscopy, a powerful technique for monitoring molecular dynamics and binding events in real-time. Recent work by Smith et al. (2024) showcased the application of 1-Ethoxy-4-fluorobenzene-derived probes in elucidating the binding mechanisms of G protein-coupled receptors (GPCRs), providing insights into receptor activation and allosteric modulation. This approach has opened new avenues for the discovery of allosteric modulators and biased agonists with improved therapeutic profiles.

The synthetic versatility of 1-Ethoxy-4-fluorobenzene has also been explored in the context of green chemistry and sustainable synthesis. A 2023 study in ACS Sustainable Chemistry & Engineering reported a novel, catalyst-free method for the functionalization of 1-Ethoxy-4-fluorobenzene under mild conditions, minimizing the use of hazardous reagents and reducing waste generation. This advancement aligns with the growing demand for environmentally friendly synthetic protocols in the pharmaceutical industry and highlights the potential of 1-Ethoxy-4-fluorobenzene as a sustainable building block.

Looking ahead, the unique properties of 1-Ethoxy-4-fluorobenzene position it as a promising candidate for further exploration in drug discovery and chemical biology. Ongoing research is investigating its potential in the development of fluorinated imaging agents, covalent inhibitors, and PROTACs (proteolysis-targeting chimeras). Additionally, the integration of computational modeling and machine learning approaches is expected to accelerate the design of novel derivatives with tailored biological activities. As the field continues to evolve, 1-Ethoxy-4-fluorobenzene is poised to play an increasingly important role in addressing unmet medical needs and advancing precision medicine.

• 458-03-7(3-Fluorophenetole)
• 203115-92-8(Benzene,1-fluoro-3-propoxy-)
• 6451-98-5(3H-Benzofuro[3a,3-b]benzofuran-3-one,1,2,4,4a,6,6a-hexahydro-6a-methoxy-4a,6,7,9-tetramethyl-, (4aa,6b,6ab,11aR*)- (9CI))
• 163848-46-2(3,4-Difluorophenetole)
• 124700-26-1(4-Fluoro-phenyl Propargyl Ether)
• 459-60-9(1-fluoro-4-methoxybenzene)
• 90213-21-1(3,6,9,12,15-Pentaoxaheptadecan-1-ol, 17-(4-fluorophenoxy)-)
• 203511-18-6(Benzene,1-fluoro-4-propoxy-)
• 1219802-94-4(4-Fluoroanisole-2,3,5,6-d4)
• 459-06-3(1-Fluoro-4-(isopropoxy)-benzene)